[Radiation therapy in high-risk and very high-risk localized or locally advanced prostate cancer : Prostate-only versus prostate plus whole-pelvic?]
Strahlenther Onkol
.
2021 Oct;197(10):939-942.
doi: 10.1007/s00066-021-01825-x.
Epub 2021 Sep 2.
[Article in German]
Authors
Martin Stuschke
1
,
Boris Hadaschik
2
Affiliations
1
Klinik für Strahlentherapie, Universitätsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland. Martin.Stuschke@uk-essen.de.
2
Klinik für Urologie, Universitätsklinikum Essen, Hufelandstr. 55, 45147, Essen, Deutschland. Boris.Hadaschik@uk-essen.de.
PMID:
34476530
PMCID:
PMC8458169
DOI:
10.1007/s00066-021-01825-x
No abstract available
Publication types
Comment
MeSH terms
Androgen Antagonists
Humans
Male
Pelvis
Prostate*
Prostatic Neoplasms* / radiotherapy
Substances
Androgen Antagonists